We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Technology Senses How Parkinson's Patients Respond to Medication

News   Apr 17, 2019 | Original story from Florida Atlantic University

 
Technology Senses How Parkinson's Patients Respond to Medication

Murtadha D. Hssayeni, (left) co-author and a Ph.D. student at FAU; Behnaz Ghoraani, Ph.D., (standing) senior author, an assistant professor in FAU's College of Engineering and Computer Science, and a fellow of FAU's I-SENSE and Brain Institute, and Lillian Boettcher, 17, a junior at FAU High School who is dual-enrolled at FAU, majoring in computer science. Credit: Florida Atlantic University

 
 
 

RELATED ARTICLES

Metabolic Dysfunction Could Be a Potential Therapy for Alzheimer’s Disease

News

A team of researchers led by Yale-NUS College has found evidence that metabolic dysfunction is a primary cause of Alzheimer's disease.

READ MORE

Bioactive Agents Improve Synthetic Bone Substitutes

News

Synthetic bone substitutes are promising materials for bone defect repair, but their efficacy can be substantially improved by bioactive agents such as growth factors. In a new study, researchers have modified beta-tricalcium phosphate (β-TCP) with increasing quantities of bone morphogenetic protein 2 (BMP-2) derived from E. coli and shown improved bone healing.

READ MORE

Drug Treats Inflammation Related to Genetic Heart Disease

News

Johns Hopkins researchers have shed new light on the role of the immune system in the progression of arrhythmogenic cardiomyopathy (ACM) and have also discovered a drug that may help prevent ACM symptoms and progression to heart failure.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Informatics Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE